Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: viral vaccines - Mymetics

Drug Profile

Research programme: viral vaccines - Mymetics

Alternative Names: Chikungunya virus infections - Mymetics; Zika virus infection - Mymetics

Latest Information Update: 28 Jun 2020

At a glance

  • Originator Mymetics Corporation
  • Class Viral vaccines; Zika virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Chikungunya virus infections; Zika virus infection

Most Recent Events

  • 28 Jun 2020 No recent reports of development identified for research development in Chikungunya-virus-infections in Netherlands
  • 28 Jun 2020 No recent reports of development identified for research development in Zika-virus-infection in Netherlands
  • 28 Jan 2016 Early research in Chikungunya virus infections in Netherlands (unspecified route)

Development Overview

Introduction

Mymetics Corporation is developing vaccines against the Chikungunya and Zika virus infections. Development is at the early research stage in the Netherlands.

As at June 2020, no recent reports of development had been identified for research development in Chikungunya-virus-infections in Netherlands, research development in Zika-virus-infection in Netherlands.

Drug Properties & Chemical Synopsis

  • Formulation unspecified
  • Class Viral vaccines, Zika virus vaccines
  • Mechanism of Action Immunostimulants
  • WHO ATC code

    J07B (Viral Vaccines)

    J07B-X (Other viral vaccines)

  • EPhMRA code

    J7E (Viral Vaccines)

Development Status

Summary Table

Indication Qualifier Patient Segment Phase Countries Route / Formulation Developers Event Date
Chikungunya virus infections - - No development reported (Research) Netherlands unspecified / unspecified Mymetics Corporation 28 Jun 2020
Zika virus infection - - No development reported (Research) Netherlands unspecified / unspecified Mymetics Corporation 28 Jun 2020

Commercial Information

Involved Organisations

Organisation Involvement Countries
Mymetics Corporation Originator USA
Mymetics Corporation Owner USA

Development History

Event Date Update Type Comment
28 Jun 2020 Phase Change - No development reported No recent reports of development identified for research development in Chikungunya-virus-infections in Netherlands Updated 28 Jun 2020
28 Jun 2020 Phase Change - No development reported No recent reports of development identified for research development in Zika-virus-infection in Netherlands Updated 28 Jun 2020
28 Jan 2016 Phase Change Early research in Chikungunya virus infections in Netherlands (unspecified route) Updated 08 Feb 2016
28 Jan 2016 Phase Change Early research in Zika virus infection in Netherlands (unspecified route) Updated 08 Feb 2016
Back to top